Electrostatic interactions enhance the spike protein’s bond to host cells NORTHWESTERN UNIVERSITY A COMPUTER MODEL SHOWING THE POLYBASIC CLEAVAGE SITES, LOCATED ON THE NOVEL CORONAVIRUS’ PROTEIN SPIKE. view more CREDIT: NORTHWESTERN UNIVERSITY EVANSTON, Ill. — Northwestern University researchers have uncovered a new vulnerability in the novel coronavirus’ infamous spike protein — illuminating a relatively simple,...
Tag: <span>pharmacologists</span>
Receptor makes mice strong and slim
Study by the University of Bonn identifies molecule that regulates two side effects of aging UNIVERSITY OF BONN CREDIT: (C) KATHARINA WISLSPERGER/UKBONN Increasing abdominal girth and shrinking muscles are two common side effects of aging. Researchers at the University of Bonn have discovered a receptor in mice that regulates both effects. Experiments with human cell...
The new COVID-19 drug remdesivir is here. Now what?
Short supplies and limits on who qualifies mean more options are needed to end the pandemic Remdesivir production Gilead Sciences plans to ramp up production of remdesivir, one of the first antiviral drugs to help COVID-19 patients recover, in order to provide 1 million 10-day course of treatment by year’s end. GILEAD SCIENCES Share this:...
New promising compound against heart rhythm disorders and clogged arteries
The pharmacological agent outperforms current drugs in most of the cases, show multiple experiments PENSOFT PUBLISHERS A new pharmacological agent demonstrates promising results for the prevention of a wide range of heart rhythm disorders, including both cardiac and brain injury-induced arrhythmias. Furthermore, the compound (SS-68) demonstrates significant activity in conditions of reduced blood flow to...